Landmark ALL-RISE® Trial Results Presented at ACC.26: CathWorks FFRangio Demonstrates Similar Clinical Outcomes to Invasive Wire-based Physiology Assessment

Contributed by: PR Newswire

Images

PR Newswire associated0
PR Newswire associated1

Tags

CathWorks-ACC

More Like This

PR Newswire associated0

CathWorks Announces the Completion of Enrollment for Landmark ALL-RISE Randomized Controlled Trial

PR Newswire associated0

Role of CathWorks FFRangio for the Assessment of Coronary Artery Disease Now Reinforced by SCAI Expert Opinion

PR Newswire associated0

CathWorks Announces Key Events for TCT 2025

PR Newswire associated0

PROVISION Study Which Met Its Primary Endpoint Now Demonstrates Similar Clinical Outcomes for FFRangio and FFR

PR Newswire associated0

CathWorks Announces Key Events for EuroPCR 2025

PR Newswire associated0

CathWorks Announces EU MDR Approval, Prominent Presence at EuroPCR and Full Launch of Co-promotion

PR Newswire associated0

FAST III trial demonstrates non-inferiority of CAAS vFFR to invasive wire-based FFR

PR Newswire associated0

MedHub-AI and Terumo partner to market AI-based FFR in Japan